Epidemiological characteristics of de novo hepatitis B infection in liver transplant recipients-An experience from a tertiary care centre in Qatar.

Arun P Nair Sreethish SasiMuna S Al-MaslamaniPrem ChandraSamar A HashimSulieman Abu JarirMoutaz F Derbala

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2020)

Orthotropic liver transplant in centers selecting donors liberally without screening for HBV poses the risk of DNHB. We recommend having protective levels of HBs antibodies before OTLX. Prophylactic antiviral treatment should be considered until peri-operative HBV transmission has been excluded by screening hepatic tissue for HBV DNA.

Keyphrases

hepatitis b virus
liver failure
tertiary care
circulating tumor
single molecule
combination therapy